IP Library Granted Patent US 9,795,515
Granted Patent B2
US 9,795,515 · App. 14/173,947 · Granted Oct 24, 2017

Micro-porous conduit

Inventors: Timothy Mark Robinson (Basingstoke, GB); Christopher Brian Locke (Bournemouth, GB)
Assignee: KCI Licensing, Inc.
A61F13/00068A61M1/0025A61M1/0084A61M1/0088A61M2205/15A61M2205/3344
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,795,515
App. No.
14/173,947
Granted
Oct 24, 2017
Kind
B2
Abstract

A porous conduit may be suitable for use in treating a tissue site, and may include a central lumen and a porous wall positioned substantially concentric about the central lumen. The porous wall may have an open porous structure that may define a plurality of interconnected pores in fluid communication with one another. As part of a system, the porous conduit may be used with a manifold adapted to be positioned at a tissue site, a sealing drape adapted to cover the manifold to provide a sealed space relative to the tissue site, and a therapy device including a reduced-pressure source. The porous conduit may be disposed in the sealed space and in fluid communication between the sealed space and the reduced-pressure source.

Claims (37)

1. A system for treating a tissue site, comprising:

a manifold adapted to be positioned proximate the tissue site;

a sealing drape adapted to cover the manifold and the tissue site to provide a sealed space between the sealing drape and the tissue site;

a porous conduit adapted to be in fluid communication with the manifold and the sealed space, comprising:

a central lumen,

a first porous wall substantially concentric about the central lumen, wherein the first porous wall has an open porous structure defining a plurality of interconnected pores in fluid communication with one another,

a barrier layer substantially concentric about the first porous wall, wherein the barrier layer is comprised of a non-porous material, and

a second porous wall substantially concentric about the barrier layer, wherein the second porous wall has an open porous structure defining a plurality of interconnected pores in fluid communication with one another, and wherein the barrier layer substantially precludes fluid communication laterally between the first porous wall and the second porous wall; and

a therapy device adapted to be in fluid communication with the porous conduit, wherein the porous conduit provides fluid communication between the manifold and the therapy device, fluid communication between the sealed space and the therapy device, or both.

2. The system of claim 1 , wherein the manifold is adapted to distribute reduced pressure to the tissue site, and wherein the manifold is comprised of a porous, hydrophobic foam.

3. The system of claim 1 , wherein the manifold is adapted to be positioned between the tissue site and the sealing drape.

4. The system of claim 1 , wherein the sealing drape is comprised of a liquid impermeable material.

5. The system of claim 1 , wherein the first porous wall and the second porous wall are each comprised of bonded particles that define the interconnected pores of the first porous wall and the interconnected pores of the second porous wall.

6. The system of claim 5 , wherein the bonded particles are sintered polymer particles.

7. The system of claim 1 , wherein the non-porous material comprising the barrier layer is liquid impermeable and hydrophobic.

8. The system of claim 1 , wherein the porous conduit has a plurality of longitudinal depressions and a plurality of longitudinal protrusions disposed about an external circumference of the porous conduit and extending lengthwise along a length of the porous conduit.

9. The system of claim 1 , wherein the porous conduit has an oval cross-sectional shape.

10. The system of claim 1 , wherein the porous conduit has a length and an external circumference defining an external surface area that is disposed in the sealed space and in fluid communication with the manifold and the sealed space.

11. The system of claim 10 , wherein the second porous wall defines the length and the external circumference of the porous conduit.

12. The system of claim 1 , wherein the central lumen and the first porous wall are each in fluid communication with the manifold and the sealed space.

13. The system of claim 1 , wherein the therapy device comprises a reduced-pressure source, a fluid source, and a pressure sensor, wherein the reduced-pressure source is in fluid communication with the central lumen, wherein the fluid instillation source is in fluid communication with the first porous wall, and wherein the pressure sensor is in fluid communication with the second porous wall.

14. The system of claim 1 , wherein the porous conduit has an insertion end positioned within the sealed space and an external end positioned exterior to the sealed space, the external end further comprising an external barrier layer positioned substantially concentric about the second porous wall, wherein the external barrier layer is comprised of a non-porous, liquid impermeable material, and wherein the external end of the porous conduit is coupled in fluid communication to the therapy device.

15. The system of claim 14 , wherein the external end of the porous conduit protrudes through an aperture in the sealing drape, and wherein the system further comprises a sealing collar sealingly engaged between the aperture in the sealing drape and the external end of the porous conduit.

16. The system of claim 1 , further comprising a conduit interface adapted to be coupled in fluid communication between the porous conduit and the therapy device, Wherein the porous conduit is positioned in the sealed space proximate an aperture in the sealing drape, and wherein the conduit interface is adapted to be coupled to the porous conduit through the aperture, and wherein the conduit interface is adapted to sealingly engage the sealing drape about the aperture in the sealing drape.

17. The system of claim 16 , further comprising a multiple lumen conduit coupled in fluid communication between the conduit interface and the therapy device, wherein the therapy device comprises a reduced-pressure source, a fluid instillation source, and a pressure sensor, and wherein the conduit interface and the multiple lumen conduit each provide a reduced-pressure lumen in fluid communication between the central lumen and the reduced-pressure source, a fluid instillation lumen in fluid communication between the first porous wall and the fluid instillation source, and a sensing lumen in fluid communication between the second porous wall and the pressure sensor.

18. The system of claim 1 , wherein the porous conduit is disposed into the manifold.

19. The system of claim 1 , wherein the porous conduit is disposed in the sealed space.

20. A system for treating a tissue site, comprising:

a manifold adapted to be positioned proximate the tissue site and to distribute reduced pressure to the tissue site;

a sealing drape adapted to cover the manifold and the tissue site to provide a sealed space between the sealing drape and the tissue site;

a porous conduit adapted to be disposed in the sealed space in fluid communication with the manifold and the sealed space, comprising:

a central lumen,

a first porous wall substantially concentric about the central lumen, wherein the first porous wall has an open porous structure defining a plurality of interconnected pores in fluid communication with one another, wherein the first porous wall is comprised of bonded particles defining the interconnected pores, and wherein the bonded particles are sintered polymer particles,

a barrier layer substantially concentric about the first porous wall, wherein the barrier layer is comprised of a non-porous, liquid impermeable material, and

a second porous wall substantially concentric about the barrier layer, wherein the second porous wall has an open porous structure defining a plurality of interconnected pores in fluid communication with one another, wherein the second porous wall is comprised of bonded particles defining the interconnected pores, wherein the bonded particles are sintered polymer particles, and wherein the barrier layer substantially precludes fluid communication laterally between the first porous wall and the second porous wall; and

a therapy device adapted to be in fluid communication with the porous conduit, comprising:

a reduced-pressure source, a fluid instillation source, and a pressure sensor, wherein the reduced-pressure source is in fluid communication with the central lumen, the fluid instillation source is in fluid communication with the first porous wall, and wherein the pressure sensor is in fluid communication with the second porous wall.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066432/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 25, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064718/0544 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 18, 2014
From: LOCKE, CHRISTOPHER BRIAN; ROBINSON, TIMOTHY MARK
To: KCI LICENSING, INC.
Reel/Frame 032237/0581 →
Continuity (2)
Provisional Application 61782713 · Mar 14, 2013
Related Publication 20140276489A1 · Sep 18, 2014